Subscribe to Newsletter

Regulation and standards

Outside the Lab Profession

Pathology in the East and the West

| Michael Schubert

Two pathologists who have practiced internationally explore the differences – and the similarities – between distant regions

Inside the Lab Guidelines and recommendations

Discarded Kidney Donations

| Liv Gaskill

Allocation kidney biopsies cause many transplant donations to be discarded every year – but are they valuable predictors of survival?

Inside the Lab Quality assurance and quality control

The Fantastic Four: Quality Control Questions for the Clinical Lab

| Satish Ramanathan

What do you know about sigma metrics and their value and applications in the clinical laboratory?

Diagnostics COVID-19

COVID-19 Vaccine Approval

| Stephanie Vine

The UK approves Pfizer/BioNTech’s COVID-19 vaccine for emergency use.

Inside the Lab Quality assurance and quality control

Where Is Diversity in Genetic Studies?

| Liv Gaskill

Meta-analyses show how genetic studies that examine only a single ethnicity or ancestry may be overlooking important hematological traits

Outside the Lab Guidelines and recommendations

Reforming the Pandemic Response

| Luke Turner

The Association for Molecular Pathology outlines five key recommendations to help laboratories better respond to pandemics

Inside the Lab Digital and computational pathology

Color Truth for Infectious Disease Imaging

| Richard Salmon

How can we effectively apply technologies like whole-slide imaging and automated diagnosis to tackle infectious diseases?

Outside the Lab Regulation and standards

The Formalin Ban: From Lethal Threat to Unique Opportunity

| Aurelio Ariza

A European ban on formalin nearly had severe consequences for medical diagnoses, but for the strong action of pathologists and medical organizations

Inside the Lab Genetics and epigenetics

Meddling with Nature

| Luke Turner

Human germline genome editing could prevent heritable genetic disorders from being passed on – but where do we currently stand?

Outside the Lab Technology and innovation

Midas Touch or Fool’s Gold?

| Richard Huang, Veronica Klepeis

The FDA has introduced new regulatory frameworks to ease digital medical devices’ transition to market – so why aren’t pathology companies using them?

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register